Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-8mjnm Total loading time: 0 Render date: 2024-03-28T17:06:56.805Z Has data issue: false hasContentIssue false

6 - Anxiety disorders and HIV disease

Published online by Cambridge University Press:  06 August 2009

Andrew C. Blalock Ph.D.
Affiliation:
Department of Psychology, Georgia State University, Atlanta, GA, USA
Sanjay M. Sharma M.D., M.B.A.
Affiliation:
Assistant Professor, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
J. Stephen McDaniel M.D.
Affiliation:
Clinical Professor of Psychiatry and Behavioral Sciences, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
Marie Josée Brouillette
Affiliation:
McGill University, Montréal
Alexandra Beckett
Affiliation:
Harvard University, Massachusetts
Get access

Summary

Introduction

Anxiety disorders may occur any time in the course of HIV disease and are most likely to become manifest at pivotal points in disease progression (Elliott, 1998). Most people with HIV respond adequately to the stress of living with the disease and are able to limit the impact of disease-related anxiety on their daily functioning and quality of life. They cope with medical problems, employment changes, family struggles, relationship difficulties, financial hardship, and the uncertainty of the disease process itself. In these circumstances, anxiety is often considered a normal psychological response to stress (American Psychological Association, 1999).

For some patients, however, the anxiety is so severe and persistent that it can significantly impair their ability to function and would be diagnosed as a disorder. In the USA, prevalence rates for anxiety disorders among patients with HIV disease range from 5–40% (McDaniel and Blalock, 2000). The estimates vary widely for two reasons:

  • anxiety is often part of a complex symptom picture that frequently includes concurrent mood disorders and psychoactive substance use disorders

  • prevalence data often come from retrospective, cross-sectional studies that do not address whether anxiety preceded or followed HIV infection.

Despite this wide range in prevalence estimates, a pattern has emerged over the last 5 years. According to several recent studies, the point prevalence of anxiety disorders in HIV-seropositive patients is not significantly different from that of HIV-seronegative clinical comparison groups.

Type
Chapter
Information
HIV and Psychiatry
Training and Resource Manual
, pp. 120 - 127
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: APA, 1994.
American Psychiatric Association. Practice Guidelines for the Treatment of Patients with HIV/AIDS. American Journal of Psychiatry, 157 (Suppl. 11) (2000): S2–62.
American Psychological Association. Project HOPE: Training Materials, Module 3: Assessment Issues and Strategies. Washington, DC, American Psychological Association, 1999.
Dew, M. A., Becker, J. T., Sanchez, J.et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychological Medicine, 27(2) (1997): 395–409.Google Scholar
Dopheide, J. and Park, S. (2001). An update on the pharmacotherapy of anxiety disorders. California Journal of Health System Pharmacy, 13(1) (2001). (Available as a live document at www.cshp.org)Google Scholar
Elliott, A.Anxiety and HIV infection. STEP Perspective, 98(1) (1998): 11–14.Google Scholar
Karasic, D. H. and Dilley, J. W. Anxiety and depression: mood and HIV disease. In The USCF AIDS Health Project Guide to Counseling, Dilley, J. W. and Marks, R., eds., pp. 227–48. San Francisco: Josey-Bass Publishers, 1998.
McDaniel, S. J. and Blalock, A. C.Diagnosis and management of HIV-related mood and anxiety disorders. New Directions in Psychiatric Services, 87 (2000): 51–6.Google Scholar
Rabkin, J. G., Ferrando, S. J., Jacobsberg, L. B. and Fishman, B.Prevalence of Axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Comprehensive Psychiatry, 38(3) (1997): 146–54.Google Scholar
Sciolla, A., Atkinson, J. H. and Grant, I. Neuropsychiatric features of HIV disease. In Practitioner's Guide to the Neuropsychiatry of HIV/AIDS, Gorp, W. G. and Buckingham, S. L., eds., pp. 106–200. New York: Guilford Press, 1998.
Sewell, M. C., Goggin, K. J., Rabkin, J. G.et al. Anxiety syndromes and symptoms among men with AIDS: a longitudinal controlled study. Psychosomatics, 41(4) (2000): 294–300.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×